-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
South Korean research team found the new coronavirus antibodies, CEVI fusion research team found antibodies that can fight the new coronavirus (Global Network) Yonhap quoted the Korean Chemical Research Institute 4 news, led by the institute of new virus fusion research team (CEVI fusion research team) has found antibodies that can fight the new coronavirus (COVID-19).
image above the sting protein structure of the new coronavirus, with sars (SARS) and MERS (Illustrated) on the left and right below (Illustrated: Yonhap/Korea Chemical Research Institute) The research team said that the stinging protein structure of the new coronavirus is very similar to that of MERS and SARS, and has confirmed that the latter's neutralizing antibodies can be combined with it.
the research team's analysis of the structural information files of the new coronavirus sting protein published on bio-Rxiv, a bioscience preprint site, predicted that the two neutralizing antibodies of SARS and one neutralizing antibody of MERS could be combined with the stingprotein of the new coronavirus, which is expected to contribute to vaccine development.
the findings were published last month in bioRxiv. The
research team also acquired a new coronavirus strain from the Disease Management Department last month and successfully acquired rnanucleic acid (RNA).
the Korea Institute of Chemistry said on March 4th that a new virus fusion research team led by the institute (CEVI Fusion Research Team) had found antibodies that could fight the new coronavirus.
According to Yonhap news agency on March 4, the team said that the neo-coronavirus's stingprotein structure is very similar to that of the Middle East Respiratory Syndrome (MERS) and SARS, and has confirmed that the latter's neutralizing antibodies can be combined with it.
the team's analysis of the structural information files of the new coronavirus sting protein, published on bio-Rxiv, a bioscience preprint site, predicted that the two neutralizing antibodies of SARS and one neutralizing antibody of MERS could be combined with the stinging protein of the new coronavirus, which is expected to contribute to vaccine development.
reported that the findings were published on BioRxiv on February 27.
team also acquired a new coronavirus strain from the Korean Disease Management Department on February 17 and successfully acquired RNA.
According to the South Korean Central Epidemic Prevention Countermeasure Department on March 4, as of 0:00 on the same day, South Korea than the previous day, 516 new cases of infection with the new coronavirus confirmed cases, a total of 5328 confirmed cases. of the
4780 cases occurred in Daegu City and Qingshan North Road, accounting for as high as 89.7%.
currently has 32 deaths.
Source: Universal.com.